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Objective:  To describe vitamin D levels and prevalence of vitamin D sufficiency, insufficiency and 
deficiency in a large, ethnically/racially diverse population of youth with type 1 diabetes (T1D) and type 
2 diabetes (T2D) in comparison to national data and examine the associations between 
clinical/demographic factors and vitamin D levels. 
Methods:  25-hydroxy vitamin D (25OHD) levels were measured in 215 youth with T1D and 326 youth 
with T2D enrolled in the Pediatric Diabetes Consortium (PDC). These levels were compared with those 
of youth of the same age without diabetes from the 2005–2006 NHANES Survey. 
Results: Vitamin D deficiency (<21ng/mL) was present in 36% of PDC participants, and insufficiency 
(21-29ng/mL) was present in an additional 34%.Thirty-six percent of age-matched youth in the 
NHANES Survey were vitamin D deficient and an additional 41% were insufficient. Deficiency or 
insufficiency varied by race/ethnicity, being highest in African-Americans (86%), intermediate in 
Hispanics (77%), and lowest in non-Hispanic whites (47%). Lower 25OHDlevels were observed in 
African American and Hispanic youth, during fall and winter, and at sites in the northern United States 
(all p-values<0.001).    Youth with T2D had significantly lower 25OHD levels than youth with T1D 
(p<0.001), but this difference was largely eliminated after adjusting for race/ethnicity and socio-
economic status. 
Conclusions: Vitamin D deficiency/insufficiency is present in a substantial proportion of youth with 
diabetes, particularly minorities, but the prevalence appears similar to that in youth without diabetes. 
This article is protected by copyright. All rights reserved.
 
 
Further studies are needed to examine whether youth with diabetes would benefit from vitamin D 
supplementation. 
  




The classic role of vitamin D is in calcium-phosphate metabolism and bone formation and the 
non-classic role is as a potential anti-inflammatory and immune-modulating hormone.  Vitamin D 
insufficiency and deficiency are common in youth (1); especially in youth with type 1 diabetes (T1D) 
(2-4) and type 2 diabetes (T2D) (5; 6).  Proposed mechanisms of an increased prevalence of vitamin D 
insufficiency and deficiency include genetic inheritance (7; 8) increased BMI (9), and concurrent 
albuminuria with enhanced excretion of vitamin D binding protein (10) and less healthy diets in youth 
with diabetes.  In addition to bone health, youth with diabetes may have additional benefits from being 
vitamin D sufficient.  Past research has demonstrated that vitamin D insufficiency/deficiency in pediatric 
diabetes may contribute to insulin resistance (3; 5; 11; 12), poor glycemic control (13), and the 
development of microvascular and macrovascular complications (14-16).   
In 2009, the Pediatric Diabetes Consortium (PDC) was formed with the objective of improving 
the care of children with diabetes through sharing of best practices, collecting outcomes data with a 
common database, and collectively advocating for improvements in pediatric diabetes care focused on 
evidence-based education. A cohort of youth with newly diagnosed T1D was enrolled in the PDC T1D 
NeOn registry by 7 U.S. pediatric diabetes centers between 2009 and 2011 and a cohort of youth with 
T2D was enrolled by 8 pediatric diabetes centers between 2012 and 2014. The large size and broad 
geographic distribution of patients within the two registries, as well as the differences in racial/ethnic 
and socio-economic characteristics between the two registries, prompted us to examine the prevalence of 
vitamin D sufficiency, insufficiency, and deficiency in these two groups of youth with diabetes. 
  





This study of the PDC T1D and T2D cohorts included 215 participants with T1D and 326 with 
T2D who had 25OHD levels measured between April 2012 and December 2013 and who were >10 
years old at the time of testing. Participants who were <10 and >22 years of age were excluded from this 
study to balance age distribution between the two cohorts. The protocols were approved by the 
Institutional Review Board (IRB) at each of the participating centers.  Informed consent was obtained 
from participants older than 18 years of age and from parents of those less than 18 years of age.  Assent 
was also obtained from participants <18 years of age as required by local IRB regulations.   
On enrollment, participants in the PDC T1D NeOn registry had to be managed at one of the 
participating PDC centers within 3 months of diagnosis. A detailed description of the PDC T1D NeOn 
registry has been published previously (17).  The PDC T2D registry included participants who were 
diagnosed with T2D using the criteria of the American Diabetes Association including being antibody 
negative, BMI >85th percentile for age and gender prior to diabetes-associated weight loss and at least 
one of the following: 1) HbA1c >6.5% (≥48 mmol/mol), 2) random glucose >200 mg/dL (11.1 mmol/L), 
3) fasting glucose >126 mg/dL (7.0 mmol/L), or 4) 2-hour OGTT glucose >200 mg/dL (11.1 mmol/L).  
Data Collection 
Demographic, socioeconomic and clinical characteristics data were collected from medical 
records and from interviews with the patient and/or parent.  Vitamin D (25OHD) levels were measured 
by the IDS-iSYS analyzer at the Mineral Metabolism Laboratory, Yale University, and New Haven, CT. 
This assay has been found to be highly accurate (18). Vitamin D deficiency was defined according to the 
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Endocrine Society Clinical Practice Guideline as a 25OHD level < 21 ng/mL and vitamin D 
insufficiency was defined as 25OHD level between 21 ng/mL and 29 ng/mL (19). One hundred and 
seven participants were fasting at the time of the blood draw and 434 were not.HbA1clevels were 
measured by point of care device or local laboratory within 28 days of the collection of the vitamin D 
sample.   
Statistical Analysis 
In order to compare our results with the national population, the distribution of 25OHDlevels 
from the NHANES survey 2005-2006 were calculated for the same age range as our sample (10-<22 
years). Mean 25OHD levels, 95% confidence interval, percent of vitamin D deficiency and insufficiency 
were calculated from our diabetes cohort and the NHANES 2005-2006 data, and sampling weights were 
used to make the NHANES survey reflective of the general US population. 
(http://wwwn.cdc.gov/nchs/nhanes/search/nhanes13_14.aspx). Race-specific 25OHD levels were also 
compared.  
Least squares regression was used to determine the association of demographic/clinical factors 
with vitamin D levels.  Multivariable models were constructed using stepwise selection methods and 
included all factors with the p-value <0.10.  Due to multiple comparisons, only factors with p-values 
<0.01 were considered statistically significant while factors with p-value <0.10 were included to adjust 
for possible confounding.  Adjusted means from multivariable analysis were defined to be the least 
squares means (ls-means) from the regression model. Interactions among all possible pairwise 
combination of factors remaining in the multiple regression model were also assessed and none were 
found to be significant (p-value <0.01).  Residual plots from the final multivariate model were evaluated 
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for approximate normal distribution, outliers and homogeneity of variance. All reported p-values are 
two-sided. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC). 
  




The demographic characteristics of the 215 study participants with T1D and 326 with T2D are 
shown in Table 1.  There were substantial differences between the two cohorts with a larger percentage 
of racial/ethnic minorities in the T2D cohort:  29% of the T1D cohort were Hispanic or Latino and 8% 
were African-American compared with 59% Hispanic or Latino and 27% African-American in the T2D 
cohort; 46% of youth with T1D were female compared with 63% of youth with T2D.  Mean age was 
14.5±2.7 and 16.1±2.5 years for T1D and T2D respectively. 
The overall mean 25OHD level was 24.8 (99 % confidence interval 23.7to 25.9) ng/mL (Table 
2). Vitamin D deficiency occurred in 36% of youth and vitamin D insufficiency occurred in an 
additional 34%, with the remaining 30% of youth having a 25OHD level above 29 ng/mL.  The 
prevalence of vitamin D deficiency and insufficiency varied according to race/ethnicity. Deficiency was 
present in 14% of non-Hispanic whites, 38% of Hispanics, and 65% of African-Americans, and 
insufficiency was present in 33% of non-Hispanic whites, 39% of Hispanics, and 21% of African-
Americans.  Of note, 9% of type 2 diabetes participants indicated they were taking vitamin D 
supplements (data on dose were not available), mean 25OHD level in these youth was 27±9 ng/mL; 
these data were not available for the T1D cohort. A sensitivity analysis excluding the 9% T2D 
participants who were taking vitamin D supplements generated similar results (data not shown). 
From the NHANES 2005-2006 data, mean age was 15.4 years (99% confidence interval 15.0 to 
15.9 years), 48% female, and median (interquartile range) BMI was 71% (40%, 91%).The national mean 
25OHD level in the same age range was 24.0 (99% confidence interval 21.9 to 26.1) ng/mL, with 
vitamin D deficiency in 36% of youth and vitamin D insufficiency in 41%.  From the NHANES 
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database, deficiency was present in 18% of non-Hispanic whites, 56% of Hispanics, and 83% of 
African-Americans, and insufficiency was present in 48% of non-Hispanic whites, 37% of Hispanics, 
and 15% of African-Americans (Table 2). The 25OHD level from NHANES data was significantly 
lower than the level from PDC cohort among each race/ethnicity group (p<0.001 for all three groups).  
Differences in unadjusted vitamin D levels were present when youth with T1D and T2D were 
compared (Supplemental Table 1). However, this was largely, though not entirely, explained by 
differences in race/ethnicity distribution between diabetes types.  As seen in Figure 1, the distribution of 
vitamin D levels was similar comparing non-Hispanic white T1D and T2D youth and comparing 
African-American T1D and T2D youth, though for both diabetes types the vitamin D levels were 
substantially lower in the African-American than white participants. For the Hispanic youth, the levels 
in T1D appeared to be slightly higher than in T2D. 
In addition to race/ethnicity and diabetes type, in univariable models, lower 25OHDlevels were 
associated with older age, female sex, BMI ≥85%, non-private insurance, lower parental education level 
and lower household income.  In addition, 25OHD levels varied substantially among the eight study 
sites and by season with the highest levels in summer and lowest levels in winter. HbA1c levels and 
diabetes duration were not significantly associated with 25OHD levels (Supplemental Table 1).  There 
was no statistically significant interaction between site and race/ethnicity. In multivariable analysis, only 
race/ethnicity (p<0.001), study site (p<0.001) and season (p<0.001) were significantly associated with 
25OHD levels; diabetes type was no longer significant (p = 0.05) (Supplemental Table 1).  
 
  




In this large, multi-center study of a diverse group of youth with diabetes, we found that vitamin 
D deficiency and insufficiency were common (36% and 34%, respectively). In multivariate analysis 
lower vitamin D levels were seen in African-American and Hispanic youth, in fall/winter months, and in 
those living in the northern United States.  When other variables were taken into account in a 
multivariate analysis, diabetes type was no longer significantly associated with 25OHD levels. 
The lower vitamin D levels seen in the African-American youth when compared to the non-Hispanic 
white youth in our study may be explained by lower levels of vitamin D binding protein secondary to 
genetic polymorphisms in the vitamin D binding protein gene (7; 8).  In addition, the lower vitamin D 
levels in the Hispanic and African-American participants also could be explained by increased skin 
pigmentation since this inhibits the synthesis of cholecalciferol, the metabolic precursor of 25OH 
vitamin D (20). Individuals with type 1 diabetes have also been demonstrated to have enhanced urinary 
excretion of vitamin D binding protein when compared to non-diabetic controls (10). In this study by 
Thrailkill et al., participants with albuminuria had more exaggerated urinary losses of vitamin D binding 
protein than participants with normoalbuminuria, and therefore, this explanation is unlikely to be a 
major factor in our study of youth with diabetes of relatively short duration. 
The prevalence of vitamin D deficiency in healthy American youth of a similar age varies 
between 19 and 24% when vitamin D deficiency is defined as <12 ng/mL (1).  Using this cut point, only 
7% (N=38) in our study had vitamin D deficiency. Although the overall level of vitamin D was similar 
in the NHANES and PDC groups, differences emerged when vitamin D levels were compared by 
race/ethnicity. When we compared our results with the 2005-2006 NHANES data from youth of the 
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same age, the vitamin D level among each race/ethnicity group was significantly higher in our study 
participants (p<0.001 for all three groups). Possible explanations for higher vitamin D levels in our PDC 
cohort include the fact that samples were drawn in 2012-2013 compared to 2005-2006 for the NHANES 
cohort. It is possible that the PDC cohorts were getting more nutritional counseling as part of their 
diabetes education that included dietary and vitamin D supplement recommendations resulting in higher 
vitamin D levels. 
Very few foods naturally have or are fortified with vitamin D, and therefore, the major source of 
vitamin D for children and adults is sun exposure.  With increased sedentary behaviors occurring 
indoors and increased use of sunscreen to prevent skin cancer, dietary vitamin D intake and vitamin D 
supplements are very important contributors to the vitamin D status of youth (19).  It is a limitation of 
our study that we did not obtain data on dietary vitamin D intake in our participants or dose of vitamin D 
supplements being used by our participants with type 2 diabetes. Amount of sun exposure is influenced 
by season of year and latitude.  Indeed, in multivariate analysis of our PDC cohort, season and study site 
were important predictors of vitamin D levels. While previous reports have suggested that obese 
individuals have lower vitamin D levels because vitamin D is fat-soluble and is sequestered in body fat 
(9), when vitamin D levels were adjusted for race/ethnicity and study site in the multivariate analysis of 
our study results, the influence of differences in BMI was no longer significant. Thus in our cohorts, 
skin pigmentation and sun exposure appear to have a greater impact on circulating vitamin D levels than 
either obesity or the type of diabetes.   
Prevalence of vitamin D deficiency in American youth with T1D as reported in the literature has 
varied from 15% - 68.5%.  For example, Svoren et al. (4) defined vitamin D deficiency as ≤ 20 ng/mL 
This article is protected by copyright. All rights reserved.
 
 
and reported that 15% of 128 youth with T1D living in Massachusetts were vitamin D deficient. In 110 
patients with T1D (5-65.1 years of age) living in Florida, 68.5% had a suboptimal vitamin D level  ≤ 30 
ng/mL (2), and 49% of youth with T1D (n=1426) followed in the SEARCH study had deficient vitamin 
D levels < 20ng/mL (3). Only the Florida study included a non-diabetic control group, and they found 
that 25OHD levels in a group of controls were similar to children with T1D and their first degree 
relatives. Much of this variation in prevalence can be explained by the disparate definitions of vitamin D 
deficiency applied in each study, the racial/ethnic composition of the patient population, the geographic 
location/latitude of the study sites, and the season of the year when samples were drawn.  In our study, 
the three variables most highly associated with vitamin D levels were race/ethnicity, study site, and 
season. 
Reports in the literature of the prevalence of vitamin D deficiency in youth with T2D are less 
common.  De las Heras et al. reported that 59% of 27 youth with T2D were vitamin D deficient with 
levels < 20 ng/mL (5). To our knowledge only Di Cesar et al. (6) compared the prevalence of vitamin D 
deficiency (<20 ng/mL) in T1D (n=50) and T2D (n=63), but the participants were all adults. They found 
that adults with T2D had more vitamin D deficiency than adults with T1D (63.5% vs. 36%). This 
difference persisted after adjusting for BMI and was unrelated to age, sex, or insulin treatment.  
Importantly, race/ethnicity were not examined in this study. In our cohort, we found that youth with 
T1D and T2D had a comparable prevalence of vitamin D deficiency after adjusting for site, 
race/ethnicity, season, gender, health insurance and family income.  
Strengths of our study include the large sample size, and the racial/ethnic and geographic 
diversity of the participant population.  In particular, this is the largest cohort of youth with T2D that 
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have had vitamin D levels systematically measured.  One weakness of our study is the lack of a control 
group of youth without diabetes, so we are unable to directly compare the prevalence of vitamin D 
deficiency in youth with and without diabetes. However, we were able to compare the prevalence in our 
cohorts with an aged matched population from the NHANES Study.  Limitations of this comparison are 
the use of different vitamin D assays for each and the fact that the NHANES data was collected in 2005-
2006, while ours were taken in 2012-2013.  Our data is also limited by the fact that we do not have 
complete data on dietary vitamin D intake or dose of vitamin D supplements being used by our T1D 
participants. 
Despite these limitations, our findings demonstrate that youth with T1D and T2D had similar 
vitamin D levels, after controlling for race/ethnicity.  In addition, vitamin D deficiency and insufficiency 
were equally common in youth with and without diabetes after adjusting for race/ethnicity and socio-
economic status. From these data, we conclude that the evaluation of vitamin D status should be 
considered in pediatric patients, especially in those with diabetes and from a racial/ethnic minority 
population. Additional research is needed to confirm whether youth with diabetes would have benefits, 
such as improved insulin resistance (3; 5; 11; 12), glycemic control (13), and prevention of diabetes 
related complications (14-16), from vitamin D supplementation.  
  




The Pediatric Diabetes Consortium and its activities are supported by the Jaeb Center for Health 
Research Foundation through an unrestrictive grant from NovoNordisk.  The University of Michigan 
Consortium center is supported by the Michigan Diabetes Research and Training Center from the 
National Institute of Diabetes and Digestive and Kidney Diseases (DK020572). J.W., C.C., P.C., and 
K.R. researched data, contributed to discussion, wrote manuscript, and reviewed/edited manuscript. 
R.B., F.B., D.S., E.C., G.K., B.G., S.W., and W.T. researched data, contributed to discussion, and 
reviewed/edited manuscript.  R.B. is the guarantor of this work and, as such, had full access to all the 
data in the study and takes responsibility for the integrity of the data and the accuracy of the data 
analysis.  G. Klingensmith reports payment for educational consultation to Eli Lilly as the planner and 
participant in a CME course for the Eli Lilly Company, and also is a paid consultant for Novo Nordisk.  
W. Tamborlane is a paid consultant for Novo Nordisk, Bristol-Meyers Squibb, Boehringer Ingelheim, 
Takeda, and Janssen.  J. Wood, K. Ruedy, R. Beck, F. Bacha, C. Connor, E. Cengiz, B. Gregg, S. Willi, 
D. Schatz, and P. Cheng report no conflict of interest. 
The Pediatric Diabetes Consortium Study Group: 
Clinical Centers: (Listed clinical center name, city, and state.  Personnel are listed as (PI) for Principal 
Investigator, (I) for co-Investigator and (C) for Coordinators.) (1) Baylor College of Medicine, 
Houston, TX: Fida Bacha, MD (PI); Morey Haymond, MD (I); Maria J. Redondo, MD, PhD (I); 
Elizabeth Johnson (C); Andrene McDonald (C) (2) Children’s Hospital of Los Angeles, Los Angeles, 
CA: Jamie Wood, MD (PI); Brian Ichihara, BA (C); Megan Lipton, MA, CCRP (C); Marisa Cohen, 
MPH (C); (3) Stanford University, Stanford, CA: Bruce Buckingham, MD (PI); Breanne Harris, BS 
This article is protected by copyright. All rights reserved.
 
 
(C); Satya Shanmugham, BS (C); (4) Barbara Davis Center for Childhood Diabetes, University of 
Colorado School of Medicine, Aurora, CO: Georgeanna J. Klingensmith, MD (PI); Heidi Haro, BA, 
BS (C); Katherine Manseau (C); (5) University of Florida, Gainesville, FL: Desmond Schatz, MD (PI); 
Janet Silverstein, MD (I); Michael J. Haller, MD (I); Jamie Thomas, BS (C); (6) Yale University, New 
Haven, CT: William V. Tamborlane, MD (I); Eda Cengiz, MD (PI); Melody Martin, CCRP (C); Amy 
Steffen, BA (C); Lori Carria, MS (C); Darryll Cappiello (C); (7) University of Michigan, Ann Arbor, 
MI: Joyce M. Lee, MD, MPH (PI); Surair Bashir (C); Ashley Eason (C); (8) Children’s Hospital of 
Philadelphia, Philadelphia, PA: Steven M. Willi, MD (PI); Tammy Mawson (C); Coordinating 
Center: Jaeb Center for Health Research, Tampa, FL: Roy W. Beck, MD, PhD; Katrina J. Ruedy, 
MSPH; Craig Kollman, PhD; Crystal G. Connor, MS, MPH; Peiyao Cheng, MPH; Beth Stevens; TJ 
Mouse. 




1.   Looker AC: Vitamin D Status: United States, 2001–2006, Hyattsville, MD : U.S. Dept. of Health 
and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 
2011 
2.   Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M: Vitamin D levels in 
subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 32:1977-
1979, 2009 
3.   N.S. T, Crandell JL, Lawrence JM, King IB, Dabelea D, Marcovina SM, D'Agostino RB, Norris JM, 
Pihoker C, Mayer-Davis EJ: Vitamin D in youth with Type 1 diabetes: prevalence of insufficiency and 
association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabetic Medicine 
30:1324-1332, 2013 
4.   Svoren BM, Volkening LK, Wood JR, Laffel LMB: Clinical and laboratory observation: Significant 
Vitamin D Deficiency in Youth with Type 1 Diabetes Mellitus. The Journal of pediatrics 154:132-134, 
2009 
5.   de las Heras J, Rajakumar K, Lee S, Bacha F, Holick MF, Arslanian SA: 25-Hydroxyvitamin D in 
Obese Youth Across the Spectrum of Glucose Tolerance From Normal to Prediabetes to Type 2 
Diabetes. Diabetes Care 36:2048-2053, 2013 
6.   Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM: Vitamin D Deficiency Is More Common 
in Type 2 Than in Type 1 Diabetes. Diabetes Care, 2006 
7.   Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, 
Karumanchi SA, Powe NR, Thadhani R: Vitamin D-binding protein and vitamin D status of black 
Americans and white Americans. The New England Journal of Medicine 369:1991-2000, 2013 
8.   Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault NA, Stotland N, Bikle D: A 
comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. The 
Journal Of Clinical Endocrinology And Metabolism 99:1631-1637, 2014 
This article is protected by copyright. All rights reserved.
 
 
9.   Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased bioavailability of vitamin D in 
obesity [corrected] [published erratum appears in AM J CLIN NUTR 2003 May;77(5):1342]. American 
Journal of Clinical Nutrition 72:690-693, 2000 
10.   Thrailkill KM, Jo C-H, Cockrell GE, Moreau CS, Fowlkes JL: Enhanced excretion of vitamin D 
binding protein in type 1 diabetes: a role in vitamin D deficiency? The Journal Of Clinical 
Endocrinology And Metabolism 96:142-149, 2011 
11.   Ganji V, Zhang X, Shaikh N, Tangpricha V: Serum 25-hydroxyvitamin D concentrations are 
associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US 
children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 
2001-2006. American Journal of Clinical Nutrition 94:225-233, 2011 
12.   Tunc O, Cetinkaya S, Kixilgun M, Aycan Z: Vitamin D status and insulin requirements in children 
and adolescent with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism 24:1037-1041, 
2011 
13.   Aljabri KS, Bokhari SA, Khan MJ: Glycemic changes after vitamin D supplementation in patients 
with type 1 diabetes mellitus and vitamin D deficiency. Annals of Saudi Medicine 30:454-458, 2010 
14.   Joergensen C, Hovind P, Schmedes A, Parving H-H, Rossing P: Vitamin D levels, microvascular 
complications, and mortality in type 1 diabetes. American Diabetes Association, 2011, p. 1081 
15.   Kaur H, Donaghue KC, Chan AK, Benitez-Aguirre P, Hing S, Lloyd M, Cusumano J, Pryke A, 
Craig ME: Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 
diabetes. American Diabetes Association, 2011, p. 1400 
16.   Young KA, Snell-Bergeon JK, Naik RG, Hokanson JE, Tarullo D, Gottlieb PA, Garg SK, Rewers 
M: Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes. 
Diabetes Care 34:454-458, 2011 
17.   Pediatric Diabetes Consortium: The Pediatric Diabetes Consortium: Improving Care of Children 
with Type 1 Diabetes Through Collaborative Research. Diabetes Technol Ther 12:685-688, 2010 
18.   Cluse ZN, Fudge AN, Whiting MJ, McWhinney B, Parkinson I, O'Loughlin PD: Evaluation of 25-
hydroxy vitamin D assay on the immunodiagnostic systems iSYS analyser. Annals of Clinical 
Biochemistry 49:159-165, 2012 
This article is protected by copyright. All rights reserved.
 
 
19.   Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, 
Weaver CM: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society 
clinical practice guideline. The Journal Of Clinical Endocrinology And Metabolism 96:1911-1930, 2011 
20.   Clemens TL, Adams JS, Henderson SL, Holick MF: Increased skin pigment reduces the capacity of 
skin to synthesise vitamin D3. Lancet 1:74-76, 1982 
21.   Kuczmarski R, Ogden C, Grummer-Strawn L, Flegal K, Guo S, Wei R, Mei Z, Curtin L, Roche A, 
Johnson C: CDC growth charts: United States. Adv Data 314:1-27, 2000 
22.   Ogden CL, Fryar CD, Carroll MD, Flegal KM: Mean body weight, height, and body mass index, 
United States 1960-2002. Advance Data:1-17, 2004 
This article is protected by copyright. All rights reserved.
 
 
Table 1: Demographic and Clinical Characteristics at Testing by Diabetes Type 

















Age (years)         
Mean ± SD 14.5 ± 2.7 16.1 ± 2.5 14.5 ± 2.6 16.5± 2.3 14.4± 2.8 16.1± 2.5 15.4±3.0 16.2 ± 2.5 
Female 99 (46%) 206 (63%) 47 (38%) 15 (63%) 31 (50%) 116 (61%) 12 (75%) 61 (70%) 
BMI (%)b         

















        
Median(quartiles) 3.2(2.7, 3.7) 
2.5(0.8, 4.7) 3.2 (2.7, 3.7) 3.1 (1.2, 4.6) 3.2 (2.7, 3.7) 2.4 (0.8, 4.6) 3.2 (2.7, 3.7) 2.4 (1.0, 5.4) 
HbA1c (% 
[mmol/mol]) 
        
Mean± SD 
8.5 ± 2.1 
(69 ± 23) 
8.1 ± 2.6 
(65 ± 28) 
8.3 ± 2.0 
(67 ± 22) 
7.0± 1.6 
(53 ± 17) 
8.5 ± 1.9 
(69 ± 20) 
8.3± 2.7 
(67 ± 29) 
8.6±2.6 
(71 ± 28) 
8.3± 2.7 
(67 ± 30) 
Health Insurance         
Private 115 (55%) 86 (26%) 89 (75%) 12 (50%) 13 (21%) 30 (16%) 7 (44%) 30 (34%) 
Parent Education         
High School or less 77 (44%) 222 (73%) 22 (23%) 14 (58%) 45 (78%) 148 (83%) 9 (75%) 50 (63 %) 
Family Income         
<$25,000 31 (22%) 99 (45%) 6 (8%) 6 (30%) 20 (39%) 68 (53%) 3 (30%) 21 (39%) 
Site         
 Los Angeles, CA 59 (27%) 83 (25%) 9 (7%) 1 (4%) 38 (61%) 75 (39%) 8 (50%) 3 (3%) 
 Houston, TX 1 (<1%) 35 (11%) 0 1 (4%) 0 24 (13%) 1 (6%) 10 (11%) 
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 Stanford, CA 25 (12%) 26 (8%) 13 (11%) 0 9 (15%) 21 (11%) 0 1 (1%) 
 Denver, CO 81 (38%) 69 (21%) 59 (48%) 6 (25%) 13 (21%) 46 (24%) 3 (19%) 14 (16%) 
 Gainesville, FL 20 (9%) 16 (5%) 18 (15%) 6 (25%) 0 2 (1%) 1 (6%) 7 (8%) 
 New Haven, CT 24 (11%) 58 (18%) 19 (15%) 7 (29%) 2 (3%) 20 (10%) 3 (19%) 26 (30%) 
 Ann Arbor, MI 5 (2%) 1 (<1%) 5 (4%) 0 0 0 0 0 
 Philadelphia, PA 0 38 (12%) 0 3 (13%) 0 3 (2%) 0 26 (30%) 
Season         
Winter 38 (18%) 66 (20%) 16 (13%) 3 (13%) 15 (24%) 37 (19%) 3 (19%) 23 (26%) 
Spring 56 (26%) 73(22%) 36 (29%) 4 (17%) 13 (21%) 41 (21%) 3 (19%) 21 (24%) 
Summer 55 (26%) 92 (28%) 33 (27%) 12 (50%) 13 (21%) 49 (26%) 8 (50%) 22 (25%) 
Fall 66 (31%) 95 (29%) 38 (31%) 5 (21%) 21 (34%) 64 (34%) 2 (13%) 21 (24%) 
a. Number of participants with missing or unknown data by type (T1D/T2D):  race/ethnicity (4/2), health insurance (5/0), parent education (39/21), family income (71/107), 
BMI% (121/29) and HbA1c (73/41). 
b. BMI percentiles adjusted for age and gender based on 2000 CDC growth charts for age 2-20 years and NHANES 1999-2002 data for adults (21; 22). 
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Table 2: Comparing Vitamin D Levels between PDC Sample and US General Populationa 
 PDC NHANES 
 










All 541d 24.8 (23.7, 25.9) 36 (31, 42) 34 (28, 39) 2496e 24.0 (21.9, 26.1) 36 (26, 45) 41 (35, 47) 
White 147 31.3 (29.0, 33.6) 14 (6, 21) 33 (23, 43) 683 27.6 (25.7, 29.4) 18 (13, 24) 48 (42, 55) 
Hispanic 253 23.4 (22.1, 24.7) 38 (30, 45) 39 (31, 47) 880 20.0 (18.2, 21.9) 56 (43, 69) 37 (27, 46) 
Black 103 19.3 (17.1, 21.5) 65 (53, 77) 21 (11, 32) 813 14.5 (12.3, 16.6) 83 (74, 92) 15 (8, 23) 
a-Estimated from NHANES 2005-2006 survey results 
b-Deficiency defined as 25OHD level < 21 ng/mL 
c-Insufficiency defined as 25OHD 21-29 ng/mL  
d-Includes 32 subjects with other race/ethnicity and 6 subjects with missing race/ethnicity. 
e-Includes 120 subjects with other race/ethnicity. 
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Figure 1. Vitamin D Levels by Race/Ethnicity and Diabetes Type. The bottom and top of 
each box denote the 25th and 75th percentiles, the line inside the box denotes the median and the 
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